Hiring in life sciences? Share your open positions with our professional community. Read more Close

Advertisement

Advancing Engineered Living Hydrogels Using Cell-Node Crosslinking.

Created on 17 Nov 2026

Authors

Rabia Fatima, Md Sohan Ahmed, Erin Reynolds, Bethany Almeida

Published in

ACS biomaterials science & engineering. Nov 16, 2026. Epub Nov 16, 2026.

Abstract

Engineered living hydrogels (ELHs) represent a convergence between biomaterial science and synthetic biology, wherein living and non-living components are combined to overcome the limitations of traditional hydrogels. While early ELHs relied on passive cell encapsulation, the next-generation of ELHs, cell-node hydrogels (CNGels), employ cells as active crosslinking nodes, fundamentally transforming hydrogel functionality and performance. This strategy enables dynamic bioactive properties, including self-healing, self-growing, self-degrading, and real-time programmable behavior through cellular sensing and adaptation. These CNGels have been successfully engineered using both mammalian and non-mammalian cells by employing a variety of strategies from metabolic glycoengineering and bioorthogonal click chemistry to SpyTag/SpyCatcher-mediated assembly, enabling a wide range of biomedical applications from tissue engineering and regenerative medicine to bioremediation. This review highlights the current fabrication strategies and mechanistic principles of CNGels, as well as provides a forward-looking perspective on optimizing CNGels for clinical and industrial deployment.

PMID:
43038134
Bibliographic data and abstract were imported from PubMed on 17 Nov 2026.

Read full publication at:
Please sign in to see all details.

Advertisement

Stats

  • Community rating n/a 0 votes
  • Reviewers' rating n/a 0 votes
  • Your rating

1-terrible, 9-excellent. How would you rate this publication? Sign in in to submit your rating.

  • Recommendations n/a n/a positive of 0 vote(s)
  • Views 9
  • Comments 0

Recommended by

  • No recommendations yet.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.

Advertisement